AVTXNasdaqPharmaceutical Preparations

Avalo Therapeutics, Inc. (AVTX) earnings date, market-implied expected move, and options open interest by expiry

6.95

+0.32 · +4.87%

post 6.95 0.00%

After hours16:00 ETdelayed

Open7.09Volume1.3MMkt cap$383.4MEPS-1.61

Day6.64 – 7.0970%52-wk6.53 – 24.272%

AVTX

Avalo Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Jan 11

before open · in 66 days

est.

Calendar

Next report

Last report

−6.22%

vs ±16.8% implied · ×0.37

shaded = implied · ▲▼ = realized

Nov 5 '26 · confirmed

Implied vs realized

Linked news

News

Largest filed tie

13F top-10 QoQ

+161.30%

shares held · 10 largest managers

13F · Jun 30 '26129d lag

127 managers

Top fund weight

0.35%

AVTX weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Avalo Therapeutics (AVTX) is expected to report on Jan 11 before open (estimated date).

Implied vs realized

2 reports

—≥ implied

Q2 FY26Aug 6 '26confirmed±19.6%▼−0.74%×0.04

Q3 FY26Nov 5 '26confirmed±16.8%▼−6.22%×0.37

quarterimplied−20%0+20%realized×

Q3 FY26±16.8%▼−6.22%×0.37

Q2 FY26±19.6%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Nov 4 close

0.32OI · 3 expiries · Nov 4 closeP/C open interest · Feb 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

295−42%Nov 2014d0.0310,1160%0.03

4,984+1%Dec 1842d0.588,5210%0.58

report · Jan 11 · before open · est.

1300%Feb 19105d402+2%

ExpiryPutsCallsP/C

Nov 2014d295−42%10,1160%0.03

Dec 1842d4,984+1%8,5210%0.58

report · Jan 11 · before open · est.

Feb 19105d1300%

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

derived from FYQ4 FY25

−23254.24%derived from FYnet margin · revenue −69.27% YoY

Revenue$59,000—

Gross profit$59,000100.00%—

Operating income−$20M−33461.02%−2.83%

Pre-tax income−$14M+55.61%

Net income−$14M−23254.24%+55.20%

Operating expenses$20M+3.14%

Tax$130,000+1081.82%

Other income$6M+153.89%

Derived: FY − Q1–Q3 · QE Dec 31 '25 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×1.54· ±7.7% vs ±5.0% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±7.7%12 of 24×1.54

PCEpersonal income & outlays±4.6%10 of 19×0.93

NFPjobs report±3.2%4 of 10×0.65

GDPgross domestic product±2.9%9 of 19×0.57

PPIproducer prices±2.8%3 of 10×0.56

CPROFcorporate profits±2.3%5 of 12×0.47

CPIconsumer prices±2.3%4 of 10×0.46

Bar = avg |move| to ±8% · tick = ±5.0% avg day · ×base = |move| ÷ ±5.0% · min 6 releases

Earnings history

EPS -0.34 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Nov 5 '26 · confirmed	-0.34	—
Q2 FY26	Aug 6 '26 · confirmed	-0.83	—
Q1 FY26	—	-0.98	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod